Skip to main content

In Vitro Fertilisation

Question for Department of Health

UIN HL5505, tabled on 9 March 2015

To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Public Health, Jane Ellison, on 25 February (HC224623) and the Written Answer by Earl Howe on 6 March (HL5131), how and why the Medicines and Healthcare Products Regulatory Agency (MHRA) was notified by the Human Fertilisation and Embryology Authority (HFEA) that manufacturers were making non-CE-marked reagents available on 4 December 2013 and 23 November 2014 if the MHRA is not notified of individual instances as reported in HFEA inspection reports; and what are the alternative CE-marked products that the clinics in question had subsequently given a commitment to use.

Answered on

23 March 2015

The Human Fertilisation and Embryology Authority (HFEA) has advised that it has an information sharing agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) so that the two organisations can better regulate the IVF sector. This can be found on the Authority’s website at:

The MHRA was notified of the information referred to by the noble Lord by email.

The HFEA has also advised that it does not hold records of what CE marked alternative products clinics have given a commitment to use.